Olaplex (OLPX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
5 Mar, 2026Executive summary
FY 2025 net sales were flat at $423.0 million, with Q4 revenue up 4.3% year-over-year to $105.1 million, stabilizing after prior declines.
Adjusted EBITDA for FY 2025 was $93.9 million (22.2% margin), with Q4 adjusted EBITDA at $12.9 million (12.2% margin), both down year-over-year due to increased investment.
Transformation initiatives included a brand relaunch, innovation pipeline expansion, and international realignment, resulting in improved brand awareness and sentiment.
Four of the top five best-selling prestige hair care launches in 2025 were introduced, and the acquisition of Purvala Bioscience strengthened the innovation pipeline.
Strategic priorities for 2026 include energizing hero products, fueling science-based innovation, and expanding a diversified go-to-market model.
Financial highlights
Q4 2025 net sales reached $105.1 million, up 4.3% year-over-year, led by strong professional and D2C channels, while specialty retail declined 14.5%.
FY 2025 adjusted gross margin was 71.8%, up 40 basis points; Q4 adjusted gross margin was 70.6%, up 200 bps year-over-year.
Operating cash flow for FY 2025 was $58.7 million; cash and equivalents at year-end were $318.7 million, with debt at $352.3 million after a $300 million voluntary repayment.
Q4 2025 net loss was $13.1 million (vs $8.8 million prior year); full-year net loss was $9.3 million versus net income of $19.5 million in 2024.
SG&A expenses increased significantly in Q4 and for the year, reflecting higher investment in marketing and transformation.
Outlook and guidance
FY 2026 net sales expected to range from $414 million to $435 million (-2% to +3% versus FY 2025); adjusted gross margin between 71%-72% and adjusted EBITDA margin of 21%-22%.
Q1 2026 sales and EBITDA expected below full-year range due to phased innovation launch and front-loaded marketing spend; sequential improvement anticipated through the year.
Guidance assumes no material tariff impact, minimal supply chain disruption, and demand weighted to the second half of 2026.
Latest events from Olaplex
- Transformation strategy targets innovation, brand demand, and global growth for long-term success.OLPX
Raymond James & Associates’ 46th Annual Institutional Investors Conference 20253 Feb 2026 - 2025 strategy drives premium haircare growth, innovation, and global expansion with strong guidance.OLPX
Barclays 18th Annual Global Consumer Staples Conference 20253 Feb 2026 - Q2 2024 sales declined 4.8%, but guidance and margin improvement targets remain on track.OLPX
Q2 20242 Feb 2026 - Transformation focuses on innovation, pro engagement, and multi-channel growth amid strong demand.OLPX
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 20242 Feb 2026 - Transformation centers on innovation, pro engagement, and a clear roadmap for sustainable growth.OLPX
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Q3 sales fell 3.6% year-over-year; FY2024 guidance lowered amid international challenges.OLPX
Q3 202416 Jan 2026 - Director elections, executive pay, and auditor ratification headline a governance-focused meeting.OLPX
Proxy Filing1 Dec 2025 - Key votes include director elections, executive pay, and auditor ratification for 2025.OLPX
Proxy Filing1 Dec 2025 - 2024 sales and profit declined, but 2025 guidance targets margin stability and transformation.OLPX
Q4 20241 Dec 2025